In the rare, familial form of AD (~1 % of cases) [2], genetic mutations in specific proteins, APP, PS1, and PS2, cause insoluble amyloid-β peptide (Aβ) aggregation and elevated levels of neurotoxic, soluble Aβ1–42 [3–5]. Here, APP is linked to Alzheimer disease.